Drug maker Lupin today said its consolidated net profit rose by 34.13 per cent to Rs 215.02 crore for the second quarter ended September 30.
The company had a net profit of Rs 160.30 crore in the same period previous fiscal, Lupin said in a statement.
Net sales of the company rose to Rs 1,405.05 crore for the July-September quarter, compared to Rs 1,114.69 crore in the corresponding period last year.
Shares of Lupin were today trading at Rs 449.50 on the Bombay Stock Exchange in late afternoon trade, up 2.58 per cent from its previous close.
